Rob Stein

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 25 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science and the Association of Health Care Journalists.

Pages

Shots - Health News
9:41 pm
Sun February 22, 2015

Kids, Allergies And A Possible Downside To Squeaky Clean Dishes

Vidhya Nagarajan for NPR

Originally published on Tue February 24, 2015 8:21 am

Could using a dishwashing machine increase the chances your child will develop allergies? That's what some provocative new research suggests — but don't tear out your machine just yet.

The study involved 1,029 Swedish children (ages 7 or 8) and found that those whose parents said they mostly wash the family's dishes by hand were significantly less likely to develop eczema, and somewhat less likely to develop allergic asthma and hay fever.

Read more
Shots - Health News
12:33 am
Mon February 9, 2015

Harnessing The Immune System To Fight Cancer

Marder says immunotherapy has side effects but is less tiring than chemotherapy.
Claire Eggers/NPR

Originally published on Tue February 10, 2015 1:35 pm

When Barbara Marder was diagnosed with lung cancer three years ago, she had part of her right lung removed, went through a round of chemotherapy and tried to move on with her life.

"I had hoped that everything was fine — that I would not create difficulty for my children, that I would get to see my grandchildren grow up," says Marder, 73, of Arnold, Md.

But a routine scan a year later found bad news: The cancer was back — this time in her other lung.

Read more
Humans
1:37 pm
Tue February 3, 2015

U.K. Lawmakers Allow Scientists To Attempt 'DNA Transplants'

Originally published on Wed February 4, 2015 8:02 am

Copyright 2015 NPR. To see more, visit http://www.npr.org/.

Transcript

AUDIE CORNISH, HOST:

Read more
Shots - Health News
2:08 pm
Wed January 21, 2015

E-Cigarettes Can Churn Out High Levels Of Formaldehyde

Vapor from an e-cigarette obscures the user's face in a London coffee bar.
Dan Kitwood Getty Images

Originally published on Thu January 22, 2015 1:55 pm

Vapor produced by electronic cigarettes can contain a surprisingly high concentration of formaldehyde — a known carcinogen — researchers reported Wednesday.

The findings, described in a letter published in the New England Journal of Medicine, intensify concern about the safety of electronic cigarettes, which have become increasingly popular.

Read more
Shots - Health News
10:42 am
Thu January 15, 2015

This Year's Flu Vaccine Is Pretty Wimpy, But Can Still Help

Bruno Mbango Enyaka gets his flu shot at a community health center in Portland, Maine, on Jan. 7.
Gabe Souza Press Herald via Getty Images

Originally published on Mon January 19, 2015 4:21 pm

As expected, this year's flu vaccine looks like it's pretty much of a dud.

The vaccine only appears to cut the chances that someone will end up sick with the flu by 23 percent, according to the first estimate of the vaccine's effectiveness by the federal Centers for Disease Control and Prevention.

Read more

Pages